Philip Morris's most recent trend suggests a bearish bias. One trading opportunity on Philip Morris is a Bear Call Spread using a strike $71.00 short call and a strike $76.00 long call offers a potential 32.63% return on risk over the next 10 calendar days. Maximum profit would be generated if the Bear Call Spread were to expire worthless, which would occur if the stock were below $71.00 by expiration. The full premium credit of $1.23 would be kept by the premium seller. The risk of $3.77 would be incurred if the stock rose above the $76.00 long call strike price.
The 5-day moving average is moving down which suggests that the short-term momentum for Philip Morris is bearish and the probability of a decline in share price is higher if the stock starts trending.
The 20-day moving average is moving down which suggests that the medium-term momentum for Philip Morris is bearish.
The RSI indicator is at 23.63 level which suggests that the stock is neither overbought nor oversold at this time.
To learn how to execute such a strategy while accounting for risk and reward in the context of smart portfolio management, and see how to trade live with a successful professional trader, view more here
LATEST NEWS for Philip Morris
Is MO Stock A Buy As Juul Writedowns Pile Up? Here's What Earnings, Altria Stock Chart Show
Mon, 02 Nov 2020 15:09:09 +0000
Tobacco giant Altria is trying to become less of a cigarette company as demand fades, but is the stock a buy right now?
10 High-Yielding Stocks That Should Please Investors Looking for Income
Tue, 27 Oct 2020 09:30:00 +0000
Interest rates are ultralow, but yields of up to 10% are still available in the U.S. stock market. Risk is often part of the package.
Philip Morris International Inc. (PM): Are Hedge Funds Right About This Stock?
Mon, 26 Oct 2020 15:13:51 +0000
Many prominent investors, including Warren Buffett, David Tepper and Stan Druckenmiller, have been cautious regarding the current bull market and missed out as the stock market reached another high in recent weeks. On the other hand, technology hedge funds weren’t timid and registered double digit market beating gains. Financials, energy and industrial stocks aren’t doing […]
PMI Announces Medicago to Supply Up to 76 Million Doses of Its Plant-Derived COVID-19 Vaccine Candidate
Fri, 23 Oct 2020 18:00:00 +0000
Since 2008, Philip Morris Investments B.V. (PMIBV), a subsidiary of Philip Morris International (PMI) (NYSE: PM), has been a shareholder of Medicago (in which it currently holds an approximately one-third equity stake) and has supported Medicago’s innovative plant-derived research and development focused on vaccines. The investment is consistent with PMI’s own efforts to leverage science and innovation. Japan-based Mitsubishi Tanabe Pharma Corporation (MTPC) is the majority shareholder and PMIBV’s partner in Medicago. Among other things, PMIBV and MTPC will contribute additional funding to support Medicago’s efforts to develop a COVID-19 vaccine candidate.
Will Staples ETFs Shine on Philip Morris' (PM) Q3 Earnings Beat?
Thu, 22 Oct 2020 20:38:08 +0000
Philip Morris (PM) delivers better-than-expected earnings results amid the coronavirus crisis.
Also on Market Tamer…
Follow Us on Facebook